Loading…
Vor Biopharma Inc. is projected to rise to $25.22 by 2027, a +32% move from its current price of $19.14. VOR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $18.37 | $19.17 | $20.00 | +0.14% |
| Jul 14 | $18.07 | $19.19 | $20.38 | +0.27% |
| Jul 15 | $17.85 | $19.22 | $20.69 | +0.41% |
| Jul 16 | $17.67 | $19.24 | $20.95 | +0.54% |
| Jul 17 | $17.52 | $19.27 | $21.20 | +0.68% |
| Jul 18 | $17.39 | $19.30 | $21.42 | +0.82% |
| Jul 19 | $17.26 | $19.32 | $21.63 | +0.95% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.26 | $19.32 | $21.63 | +0.95% |
| Week 2 | $16.63 | $19.51 | $22.88 | +1.92% |
| Week 3 | $16.20 | $19.69 | $23.94 | +2.89% |
| Week 4 | $15.87 | $19.88 | $24.90 | +3.87% |
| Week 5 | $15.60 | $20.07 | $25.82 | +4.86% |
| Week 6 | $15.38 | $20.26 | $26.70 | +5.86% |
| Week 7 | $15.18 | $20.46 | $27.56 | +6.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd.
for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
The company is categorized in Healthcare and operates in the pharmaceutical research and development space, pursuing therapies for autoimmune conditions. Its focus on telitacicept positions it within autoimmune disease therapeutics as a clinical-stage entity headquartered in the United States.
Vor Biopharma Inc. (VOR) trades with a current price of $19.14 and a market cap of $1.04B, ranking 2519 by market capitalization. The stock sits in the Healthcare sector and has a defined price trajectory according to year-by-year forecasts.
In 2026, the average forecast price is $19.14 with a min of $10.58 and a max of $31.81, reflecting a neutral sentiment and a 0 ROI. The forecast suite shows rising long-term potential, with later years projecting bullish sentiment and substantially higher average prices, culminating in strong upside through 2050.
A major floor 47.8% below — a decisive break under it would weaken the trend.
The nearest floor, 32.1% below — buyers have tended to step in here.
The nearest ceiling, 7.6% above — a clean break opens room to run.
A major ceiling 31.5% above — clearing it would confirm fresh momentum.
Key VOR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VOR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.88 | Sell | $19.52 | Sell |
| MA 10 | $19.15 | Sell | $18.84 | Buy |
| MA 20 | $16.84 | Buy | $17.56 | Buy |
| MA 50 | $15.58 | Buy | $16.14 | Buy |
| MA 100 | $15.21 | Buy | $15.89 | Buy |
| MA 200 | $16.75 | Buy | $17.25 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.44 | Neutral |
| Stoch RSI (14) | 50.67 | Neutral |
| CCI (20) | 64.34 | Neutral |
| Williams %R (14) | -23.73 | Info |
| MACD (12,26,9) | 0.34 | Buy |
| ROC (12) | 28.89 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 76.27 | Neutral |
| TRIX (15) | 1.03 | Buy |
| Awesome (5,34) | 4.16 | Buy |
| Ultimate (7,14,28) | 64.05 | Neutral |
| Momentum (10) | 4.21 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 20.08 | Sell |
| ADX (14) | 24.54 | Buy |
| ATR (14) | 0.61 | Info |
The 30-day technical picture is bullish overall, with a bullish sentiment signal accompanying the near-term setup. RSI14 is 60, and the price is trading near major averages with a SMA50 of $15.58 and a SMA200 of $16.75.
Key support is at $13.00 and resistance at $20.59, framing a 30-day range from a low of $14.46 to a high of $25.34. Annualized volatility stands at 80%, highlighting notable price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.58 | $19.14 | $31.82 | 0% | Neutral | |
| $19.04 | $25.22 | $35.89 | +32% | Bullish | |
| $22.07 | $30.62 | $45.97 | +60% | Bullish | |
| $22.56 | $32.55 | $50.91 | +70% | Bullish | |
| $23.36 | $34.90 | $56.51 | +82% | Bullish | |
| $30.73 | $47.42 | $79.08 | +148% | Bullish | |
| $36.60 | $58.24 | $99.72 | +204% | Bullish | |
| $41.14 | $67.39 | $118.14 | +252% | Bullish | |
| $42.51 | $71.61 | $128.29 | +274% | Bullish | |
| $39.48 | $68.33 | $124.90 | +257% | Bullish | |
| $62.94 | $123.69 | $245.58 | +546% | Bullish | |
| $136.10 | $302.45 | $675.51 | +14.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.58 | $19.14 | $24.19 | +0.00% |
| August 2026 | $17.88 | $21.42 | $26.58 | +11.91% |
| September 2026 | $17.88 | $21.66 | $27.34 | +1.13% |
| October 2026 | $18.12 | $22.17 | $28.38 | +2.34% |
| November 2026 | $19.21 | $23.69 | $30.69 | +6.89% |
| December 2026 | $19.56 | $24.30 | $31.82 | +2.57% |
Click any year to see its month-by-month VOR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Vor Biopharma Inc.'s 2026 outlook centres on $19.14, within a $10.58 to $31.82 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, VOR could reach as high as $35.89, with a base case around $25.22 and support toward $19.04 — roughly +32% from $19.14. Buyers look set to stay in control over this stretch.
Expect VOR to range from $22.07 to $45.97 through 2028. The $30.62 average target implies a +60% move from current prices. That is up +21% on the projected 2027 average. Momentum favours further upside here.
The VOR price prediction for 2029 points to an average of $32.55 (low $22.56, high $50.91) — a potential gain of +70% on today's $19.14. Buyers look set to stay in control over this stretch.
In 2030, VOR is projected to trade between $23.36 and $56.51, averaging $34.90 — a potential gain of +82% from today's $19.14. That is up +7% on the projected 2029 average. Momentum favours further upside here.
Vor Biopharma Inc.'s 2031 outlook centres on $47.42, within a $30.73 to $79.08 range. That is up +36% on the projected 2030 average. That marks a +148% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, VOR could reach as high as $99.72, with a base case around $58.24 and support toward $36.60 — roughly +204% from $19.14. Momentum favours further upside here.
Expect VOR to range from $41.14 to $118.14 through 2033. The $67.39 average target implies a +252% move from current prices. That is up +16% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The VOR price prediction for 2034 points to an average of $71.61 (low $42.51, high $128.29) — a potential gain of +274% on today's $19.14. Momentum favours further upside here.
In 2035, VOR is projected to trade between $39.48 and $124.90, averaging $68.33 — a potential gain of +257% from today's $19.14. That is -5% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Vor Biopharma Inc.'s 2040 outlook centres on $123.69, within a $62.94 to $245.58 range. That is up +81% on the projected 2035 average. That marks a +546% change versus current levels. Momentum favours further upside here.
By 2050, VOR could reach as high as $675.51, with a base case around $302.45 and support toward $136.10 — roughly +14.8x from $19.14. Buyers look set to stay in control over this stretch.
Investing $1,000 in VOR today (≈ 52.246604 VOR) could be worth
$15,802.21
+$14,802.21 (+1480%) by 2050 · US Dollar
Based on the average projected VOR price of $302.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VORwould be worth at today's price.
$1,000 invested in VOR on Jul 10, 2025 (≈ 21.645021 VOR) would be worth
$414.29
-$585.71 (-58.6%) today · 0.41× · US Dollar
Based on a VOR entry price of $46.2 vs. today's $19.14.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20.59 | $929.58 | -7.0% |
| 1 month ago | $13 | $1,472.31 | +47.2% |
| 3 months ago | $15.47 | $1,237.23 | +23.7% |
| 6 months ago | $14.15 | $1,352.65 | +35.3% |
| 1 year ago | $46.2 | $414.29 | -58.6% |
| All time (5.0y) ago | $336.8 | $56.83 | -94.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VOR forecast.
Our base-case forecast reaches $38.00 around 2031.
Implied market cap at $38.00: $2.06B
The multi-year forecast points to a sustained upside from 2026 through 2050. In 2030 the average price is projected at $34.88 with an ROI of 82.2 and bullish sentiment, building on the trajectory from earlier years. By 2040, the average is forecast at $123.93 with an ROI of 547.5, and the sentiment remains bullish.
The 2050 forecast shows an average of $302.19 with an ROI of 1478.9, continuing the bullish stance across the horizon.
Overall, the longer-term view signals meaningful upside potential, with average prices climbing significantly and ROI expanding over time. These are estimates and not guarantees, and actual results will depend on market conditions, clinical outcomes, and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $34.88 with an ROI of 82.2 and bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with rising average prices and higher ROIs, including an average of $34.88 by 2030 and $302.19 by 2050; 2026 is neutral.
Yes. The forecast includes max prices above $100 in later years, with 2033 max $118.15 and 2034 max $128.49, and even higher maxima such as $246.07 by 2040 and $674.95 by 2050.
Current price is $19.14 and market cap is $1.04B.
Bullish sentiment with RSI 60, SMA50 $15.58, SMA200 $16.75. Support is at $13.00 and resistance at $20.59, with a 30-day range of $14.46 to $25.34 and annualized volatility of 80%.
Vor Biopharma Inc. Community Discussion
0Share your Vor Biopharma Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.